Results

Total Results: 2,139 records

Showing results for "drugs".

1. Club Drugs | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/health-topics/club-drugs

2. Diabetes-Drugs-Utilization Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
   March 01, 2011 - Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 Diabetes Treatment … Several types of insulin and other injectable drugs such as amylin analogs and glucagon-like peptide … Drugs Aging 2009;26(Suppl 1):53-62. 3. Abbatecola AM, Maggi S, Paolisso G. … Drugs Aging 2008;25(11):913-25. 4. Feil D, Weinreb J, Sultzer D. … Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009.

3. Hypertension-Drugs-Utilization Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
   January 25, 2011 - Further, it examines costs of antihypertensive drugs. … In 2009, the total drug cost for antihypertensive drugs was $4.3 bil- lion. … Identification of Antihypertensive Drugs and Classes: Oral prescriptions of anti- hypertensive drugs … Table 2: Antihypertensive drugs examined in this brief Drug Class Drugs Angiotensin-converting enzyme … Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter?

4. Cancer-Drugs-Utilization Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
   January 01, 2011 - Drug Information, DrugPoints, Clinical Pharmacology, DRUGDEX, National Comprehensive Cancer Network Drugs

5. Drugs and Young People | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/health-topics/drugs-and-young-people
   January 17, 2012 - Strategies To Improve Cardiovascular Risk Factors in People With Serious Mental Illness: A Comparative Effectiveness Review Research Protocol Archived January 17, 2012 Strategies for Improving the Lives of Women Aged 40 and Above Living with HIV/AIDS Research Protocol Archived Marc…

6. Cancer-Drugs-Utilization-Cost Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
   January 01, 2011 - expen- ditures treated either cancer or potential sequelae of cancer (e.g., anemia).4 Two of these drugs … Using 2006 data, the Centers for Medicare & Medicaid Services (CMS) reported on the top 100 Part D drugs … Limits on Medicare’s ability to control rising spending on cancer drugs. … Top 100 drugs by utilization and class variations in generic dispensing rates. … Available at: www.aarp.org/health/drugs- supplements/info-2007/fs136_biologics.html.

7. Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 | Effective Health Care Program
   effectivehealthcare.ahrq.gov/products/diabetes-drugs-utilization
   April 05, 2012 - Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 … April 05, 2012 Research Report Data Points #9: Utilization of antidiabetic drugs

8. Data Points #8: Utilization of antihypertensive drug classes among Medicare beneficiaries with hypertension, 2007 to 2009 | Effective Health Care Program
   effectivehealthcare.ahrq.gov/products/hypertension-drugs-utilization
   November 16, 2011 - Data Points #8: Utilization of antihypertensive drug classes among Medicare beneficiaries with hypertension, 2007 to 2009 Timeline November 11, 2011 Topic Initiated November 16, 2011 Research Report Data Points #8: Utilization of antihypertensive drug classe…

9. Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug Events Related to Anticoagulants | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/high-risk-drugs/protocol

10. Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/diabetes-drugs-utilization/research/

11. Data Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009 | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization
    August 26, 2011 - Data Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009 Timeline August 26, 2011 Topic Initiated August 26, 2011 Research Report Data Points #7: Utilization of anticancer biologic p…

12. Data Points #8: Utilization of antihypertensive drug classes among Medicare beneficiaries with hypertension, 2007 to 2009 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/hypertension-drugs-utilization/research
    November 16, 2011 - Most patients with hypertension will require two or more antihypertensive drugs to control their blood … This Data Points brief explores the prevalence of hypertension and utilization of antihypertensive drugs … Further, it examines costs of antihypertensive drugs.

13. Data Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization/research
    August 26, 2011 - Drug Information, DrugPoints, Clinical Pharmacology, DRUGDEX, National Comprehensive Cancer Network Drugs

14. Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization-cost
    August 26, 2011 - Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Timeline August 26, 2011 Topic Initiated August 26, 2011 Research Report Data Points #6: Utilization and cost of anticancer biologic products among M…

15. S13 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
    October 01, 2007 - Historically, those who investigate the effects of mar- keted pharmaceuticals have focused on the risk … Unique Problems in the Study of Pharmaceuticals Exposure misclassification is a unique challenge in … Indeed, the confounders of concern are usually other drugs or other diseases. … In addition, studies of pharmaceuticals, especially stud- ies of the effectiveness of pharmaceuticals … CONCLUSIONS The goal of our research community is to optimize the use of pharmaceuticals by improving

16. Addressing Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/diabetes-oral-drugs-safety-knowledge-gaps
    January 01, 2005 - Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs … Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs

17. Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/eccs-2006/white-paper
    September 30, 2006 - Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers White Paper September … Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers (PPT, 153 kb) What … Evidence" to Healthcare Consumers: Applying Social Marketing to Evidence About the Harms and Benefits of Pharmaceuticals

18. Reducing Adverse Drug Events Related to Anticoagulant Use in Adults | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/high-risk-drugs/rapid-research

19. Report of a Pilot Project: Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/horizon-scan/research-2015
    October 01, 2015 - Health care horizon scanning is an activity undertaken to identify technological and system innovations (pharmaceuticals … New drugs for treating one disease—direct-acting oral antivirals for interferon-free treatment of hepatitis … When considering categories of these interventions, such as drugs, devices, and procedures, new pharmaceuticals … /biotechnologies and new off-label uses of existing pharmaceuticals constituted about 60 percent of estimated … annual spend of more than $1 billion each totaled $35 billion in estimated spend (including the new oral drugs

20. Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization-cost/research